CooperVision MiSight 1 day Contact Lenses (IMAGE) McDougall Communications Caption At the International Myopia Conference, CooperVision will offer new insights into the treatment efficacy of the fastest growing eyes fit with MiSight® 1 day contact lenses, derived from the world’s longest-running soft contact lens study among children. The international seven-year MiSight® 1 day clinical trial has become the gold standard for evaluating myopia control effectiveness because of its robust design, multi-country enrollment, and extent of professionally published and peer-reviewed data. Credit CooperVision Usage Restrictions None License Original content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.